| Previous close | 80.59 |
| Open | 79.95 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 79.10 - 80.58 |
| 52-week range | 65.48 - 96.34 |
| Volume | 1,193,431 |
| Avg. volume | 630,573 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Yahoo Finance
Coronavirus update: Vaccine makers ramp up manufacturing as Trump stirs debate; NYC to delay school reopen
Drug makers moved quickly to ramp up vaccine manufacturing capacity, as a new debate erupted over how quickly it could be deployed to the general population.
- Investing.com
Stocks - Europe Seen Higher Amid Virus Treatment Optimism
Elsewhere, gold futures fell 0.2% to $1,942.30/oz, continuing a second consecutive week of losses. EUR/USD traded 0.1% higher at 1.1803.
- Yahoo Finance Video
It's important that the government invests in vaccines : Dr. Dan Barouch
Harvard Medical School's Dr. Dan Barouch joins 'Influencers with Andy Serwer' to discuss why the U.S. government should support COVID-19 vaccine research.
© 2020 Verizon Media. All rights reserved.
